AZN

#5322
AstraZeneca PLC - American Depositary Shares
185.7 1 USD
-0.15%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
184.74
185.75
Faixa anual
68.62
212.71
Mudança diária
-0.15%
Mudança mensal
-1.47%
Mudança em 6 meses
+99.80%
Mudança anual
+161.27%
Fechamento anterior
185.9 8
Open
184.8 6
Mínimo
184.7 4
High
185.7 5
Volume
822
Abrir gráfico completo Full chart

Financials

Visão geral Relatórios Estatísticas Dividendos
Trimestral Ano
  • Market Capitalization N/A
  • Employee 96 K
  • Founded 1999
  • CEO Pascal Soriot
  • Website www.astrazeneca.com
  • Headquarter United Kingdom
  • FIGI BBG000BZ0DK8
  • Industry Fabricantes de medicamentos - gerais
Receita total
Lucro líquido
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa

AstraZeneca PLC - American Depositary Shares

AstraZeneca plc is a Swedish–British multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, UK. It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. The company was founded in 1999 through the merger of the Swedish Astra AB and the British Zeneca Group. Zeneca shareholders received 53.5% of the shares, while Astra shareholders received the remaining 46.5%. Its portfolio includes primary and speciality care, coverage for rare diseases, and a robust global presence across various regions. Since the merger it has been among the world's largest pharmaceutical companies and has made numerous corporate acquisitions, including Cambridge Antibody Technology, MedImmune, Spirogen and Definiens. It has its research and development concentrated in three strategic centres: Cambridge, UK; Gothenburg, Sweden; and Gaithersburg, Maryland, US. AstraZeneca traces its earliest corporate history to 1913, when Astra AB was formed by a large group of doctors and apothecaries in Södertälje.

Notícias